Labé, C.; Chehadeh, A.; Winter, A.; Pracht, S.; Stuebner, K.M.; Lewellen, M.; Eskander, B.; O’Sullivan, M.G.; Tabaran, A.-F.; Ober, C.;
et al. Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care. Vet. Sci. 2025, 12, 921.
https://doi.org/10.3390/vetsci12100921
AMA Style
Labé C, Chehadeh A, Winter A, Pracht S, Stuebner KM, Lewellen M, Eskander B, O’Sullivan MG, Tabaran A-F, Ober C,
et al. Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care. Veterinary Sciences. 2025; 12(10):921.
https://doi.org/10.3390/vetsci12100921
Chicago/Turabian Style
Labé, Courtney, Andrea Chehadeh, Amber Winter, Sara Pracht, Kathy M. Stuebner, Mitzi Lewellen, Bishoy Eskander, M. Gerard O’Sullivan, Alexandru-Flaviu Tabaran, Christopher Ober,
and et al. 2025. "Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care" Veterinary Sciences 12, no. 10: 921.
https://doi.org/10.3390/vetsci12100921
APA Style
Labé, C., Chehadeh, A., Winter, A., Pracht, S., Stuebner, K. M., Lewellen, M., Eskander, B., O’Sullivan, M. G., Tabaran, A.-F., Ober, C., Henson, M. S., Seelig, D., Russell, S. J., Modiano, J. F., Naik, S., & Makielski, K. M.
(2025). Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care. Veterinary Sciences, 12(10), 921.
https://doi.org/10.3390/vetsci12100921
